Erythrocytes as a preferential target of oxidative stress in blood

References

• Tanaka K, Mizushima T, Saeki Y. The proteasome: molecular machinery and pathophysiological roles. Biol Chem. 2012;393(4):217–234.
   PubMed Web of Science ®Google Scholar
• Morishita H, Mizushima N. Diverse cellular roles of autophagy. Annu Rev Cell Dev Biol. 2019;35:453–475.
   PubMed Web of Science ®Google Scholar
• Roux-Dalvai F, Gonzalez de Peredo A, Simó C, et al. Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol Cell Proteomics. 2008;7(11):2254–2269.
   PubMed Web of Science ®Google Scholar
• Rifkind JM, Nagababu E. Hemoglobin redox reactions and red blood cell aging. Antioxid Redox Signal. 2013;18(17):2274–2283.
   PubMed Web of Science ®Google Scholar
• Cox AG, Winterbourn CC, Hampton MB. Measuring the redox state of cellular peroxiredoxins by immunoblotting. Methods Enzymol. 2010;474:51–66.
   PubMed Web of Science ®Google Scholar
• Davies MJ, Fu S, Wang H, et al. Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radic Biol Med. 1999;27(11–12):1151–1163.
   PubMed Web of Science ®Google Scholar
• Grune T. Oxidized protein aggregates: formation and biological effects. Free Radic Biol Med. 2020;150:120–124.
   PubMed Web of Science ®Google Scholar
• Zivot A, Lipton JM, Narla A, et al. Erythropoiesis: insights into pathophysiology and treatments in 2017. Mol Med. 2018;24(1):11.
   PubMedGoogle Scholar
• Zhen R, Moo C, Zhao Z, et al. Wdr26 regulates nuclear condensation in developing erythroblasts. Blood. 2020;135(3):208–219.
   PubMed Web of Science ®Google Scholar
• Thom CS, Traxler EA, Khandros E, et al. Trim58 degrades dynein and regulates terminal erythropoiesis. Dev Cell. 2014;30(6):688–700.
   PubMed Web of Science ®Google Scholar
• Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol. 2011;12(1):9–14.
   PubMed Web of Science ®Google Scholar
• Chen CY, Pajak L, Tamburlin J, et al. The effect of proteasome inhibitors on mammalian erythroid terminal differentiation. Exp Hematol. 2002;30(7):634–639.
   PubMed Web of Science ®Google Scholar
• Nguyen AT, Prado MA, Schmidt PJ, et al. UBE2O remodels the proteome during terminal erythroid differentiation. Science. 2017;357(6350):eaan0218.
   PubMed Web of Science ®Google Scholar
• Bauer C, Kurtz A. Oxygen sensing in the kidney and its relation to erythropoietin production. Annu Rev Physiol. 1989;51:845–856.
   PubMed Web of Science ®Google Scholar
• Sato Y, Yanagita M. Renal anemia: from incurable to curable. Am J Physiol Renal Physiol. 2013;305(9):F1239–F1248.
   PubMed Web of Science ®Google Scholar
• Canavesi E, Alfieri C, Pelusi S, et al. Hepcidin and HFE protein: iron metabolism as a target for the anemia of chronic kidney disease. World J Nephrol. 2012;1(6):166–176.
   PubMedGoogle Scholar
• Pagani A, Nai A, Silvestri L, et al. Hepcidin and anemia: a tight relationship. Front Physiol. 2019;10:1294.
   PubMed Web of Science ®Google Scholar
• Ganz T. Anemia of inflammation. N Engl J Med. 2019;381(12):1148–1157.
   PubMed Web of Science ®Google Scholar
• Fraenkel PG. Anemia of inflammation: a review. Med Clin North Am. 2017;101(2):285–296.
   PubMed Web of Science ®Google Scholar
• Brissot P, Pietrangelo A, Adams PC, et al. Haemochromatosis. Nat Rev Dis Primers. 2018;4:18016.
   PubMed Web of Science ®Google Scholar
• Lippi G, Mattiuzzi C. Updated worldwide epidemiology of inherited erythrocyte disorders. Acta Haematol. 2020;143(3):196–197.
   PubMed Web of Science ®Google Scholar
• Grace RF, Glader B. Red blood cell enzyme disorders. Pediatr Clin North Am. 2018;65(3):579–595.
   PubMed Web of Science ®Google Scholar
• Bianchi P, Fermo E, Lezon-Geyda K, et al. Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency. Am J Hematol. 2020;95(5):472–482.
   PubMed Web of Science ®Google Scholar
• Grace RF, Bianchi P, van Beers EJ, et al. Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study. Blood. 2018;131(20):2183–2192.
   PubMed Web of Science ®Google Scholar
• Grace RF, Mark Layton D, Barcellini W. How we manage patients with pyruvate kinase deficiency. Br J Haematol. 2019;184(5):721–734.
   PubMed Web of Science ®Google Scholar
• Beutler E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood. 2008;111(1):16–24.
   PubMed Web of Science ®Google Scholar
• Mason PJ, Bautista JM, Gilsanz F. G6PD deficiency: the genotype-phenotype association. Blood Rev. 2007;21(5):267–283.
   PubMed Web of Science ®Google Scholar
• Pandolfi PP, Sonati F, Rivi R, et al. Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J. 1995;14(21):5209–5215.
   PubMed Web of Science ®Google Scholar
• Cheah FC, Peskin AV, Wong FL, et al. Increased basal oxidation of peroxiredoxin 2 and limited peroxiredoxin recycling in glucose-6-phosphate dehydrogenase-deficient erythrocytes from newborn infants. FASEB J. 2014;28(7):3205–3210.
   PubMed Web of Science ®Google Scholar
• Ware RE, de Montalembert M, Tshilolo L, et al. Sickle cell disease. Lancet. 2017;390(10091):311–323.
   PubMed Web of Science ®Google Scholar
• Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155–167.
   PubMed Web of Science ®Google Scholar
• Longo L, Vanegas OC, Patel M, et al. Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal. EMBO J. 2002;21(16):4229–4239.
   PubMed Web of Science ®Google Scholar
• Pretsch W, Charles DJ, Merkle S. X-linked glucose-6-phosphate dehydrogenase deficiency in Mus musculus. Biochem Genet. 1988;26(1–2):89–103.
   PubMed Web of Science ®Google Scholar
• Hecker PA, Leopold JA, Gupte SA, et al. Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease. Am J Physiol Heart Circ Physiol. 2013;304(4):H491–H500.
   PubMed Web of Science ®Google Scholar
• Sanders S, Smith DP, Thomas GA, et al. A glucose-6-phosphate dehydrogenase (G6PD) splice site consensus sequence mutation associated with G6PD enzyme deficiency. Mutat Res. 1997;374(1):79–87.
   PubMed Web of Science ®Google Scholar
• Bhattacharya D, Saha S, Basu S, et al. Differential regulation of redox proteins and chaperones in HbEβ-thalassemia erythrocyte proteome. Proteomics Clin Appl. 2010;4(5):480–488.
   PubMed Web of Science ®Google Scholar
• De Franceschi L, Bertoldi M, De Falco L, et al. Oxidative stress modulates heme synthesis and induces peroxiredoxin-2 as a novel cytoprotective response in β-thalassemic erythropoiesis. Haematologica. 2011;96(11):1595–1604.
   PubMed Web of Science ®Google Scholar
• Lithanatudom P, Smith DR. Analysis of protein profiling studies of β-thalassemia/Hb E disease. Proteomics Clin Appl. 2016;10(11):1093–1102.
   PubMed Web of Science ®Google Scholar
• Romanello KS, Teixeira KKL, Silva JPMO, Nagamatsu ST, et al. Global analysis of erythroid cells redox status reveals the involvement of Prdx1 and Prdx2 in the severity of beta thalassemia. PLoS One. 2018;13(12):e0208316.
   PubMed Web of Science ®Google Scholar
• Matte A, Low PS, Turrini F, et al. Peroxiredoxin-2 expression is increased in beta-thalassemic mouse red cells but is displaced from the membrane as a marker of oxidative stress. Free Radic Biol Med. 2010;49(3):457–466.
   PubMed Web of Science ®Google Scholar
• Matte A, De Falco L, Federti E, et al. Peroxiredoxin-2: a novel regulator of iron homeostasis in ineffective erythropoiesis. Antioxid Redox Signal. 2018;28(1):1–14.
   PubMed Web of Science ®Google Scholar
• May C, Rivella S, Chadburn A, et al. Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene. Blood. 2002;99(6):1902–1908.
   PubMed Web of Science ®Google Scholar
• De Franceschi L, Bertoldi M, Matte A, et al. Oxidative stress and β-thalassemic erythroid cells behind the molecular defect. Oxid Med Cell Longev. 2013;2013:985210.
   PubMed Web of Science ®Google Scholar
• Rund D. Thalassemia 2016: modern medicine battles an ancient disease. Am J Hematol. 2016;91(1):15–21.
   PubMed Web of Science ®Google Scholar
• Lisowski L, Sadelain M. Current status of globin gene therapy for the treatment of beta-thalassaemia. Br J Haematol. 2008;141(3):335–345.
   PubMed Web of Science ®Google Scholar
• Nagel RL, Fleming AF. Genetic epidemiology of the beta s gene. Baillieres Clin Haematol. 1992;5(2):331–365.
   PubMedGoogle Scholar
• Alabdulaali MK. Sickle cell disease patients in eastern province of Saudi Arabia suffer less severe acute chest syndrome than patients with African haplotypes. Ann Thorac Med. 2007;2(4):158–162.
   PubMedGoogle Scholar
• Kato GJ, Steinberg MH, Gladwin MT. Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest. 2017;127(3):750–760.
   PubMed Web of Science ®Google Scholar
• Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017;376(16):1561–1573.
   PubMed Web of Science ®Google Scholar
• Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8(12):1383–1389.
   PubMed Web of Science ®Google Scholar
• Kassa T, Jana S, Strader MB, et al. Sickle cell hemoglobin in the ferryl state promotes βCys-93 oxidation and mitochondrial dysfunction in epithelial lung cells (E10). J Biol Chem. 2015;290(46):27939–27958.
   PubMed Web of Science ®Google Scholar
• Jana S, Strader MB, Meng F, et al. Hemoglobin oxidation-dependent reactions promote interactions with band 3 and oxidative changes in sickle cell-derived microparticles. JCI Insight. 2018;3(21):120451.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dai Y, Wen J, et al. Detrimental effects of adenosine signaling in sickle cell disease. Nat Med. 2011;17(1):79–86.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Berka V, Song A, et al. Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression. J Clin Invest. 2014;124(6):2750–2761.
   PubMed Web of Science ®Google Scholar
• Sun K, Zhang Y, Bogdanov MV, et al. Elevated adenosine signaling via adenosine A2B receptor induces normal and sickle erythrocyte sphingosine kinase 1 activity. Blood. 2015;125(10):1643–1652.
   PubMed Web of Science ®Google Scholar
• Sun K, D’Alessandro A, Ahmed MH, et al. Structural and functional insight of sphingosine 1-phosphate-mediated pathogenic metabolic reprogramming in sickle cell disease. Sci Rep. 2017;7(1):15281.
   PubMedGoogle Scholar
• Fiesco-Roa MO, Giri N, McReynolds LJ, et al. Genotype-phenotype associations in Fanconi anemia: a literature review. Blood Rev. 2019;37:100589.
   PubMed Web of Science ®Google Scholar
• Kumari U, Ya Jun W, Huat Bay B, et al. Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi anemia cells. Oncogene. 2014;33(2):165–172.
   PubMed Web of Science ®Google Scholar
• Hadjur S, Ung K, Wadsworth L, et al. Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismutase. Blood. 2001;98(4):1003–1011.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay SS, Leung KS, Hicks MJ, et al. Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia. J Cell Biol. 2006;175(2):225–235.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 4th ed. Oxford (UK): Oxford University Press; 2007.
   Google Scholar
• Winterbourn CC. Oxidative reactions of hemoglobin. Methods Enzymol. 1990;186:265–272.
   PubMed Web of Science ®Google Scholar
• Johnson RM, Goyette G, Jr, Ravindranath Y, et al. Hemoglobin autoxidation and regulation of endogenous H2O2 levels in erythrocytes. Free Radic Biol Med. 2005;39(11):1407–1417.
   PubMed Web of Science ®Google Scholar
• Umbreit J. Methemoglobin-it’s not just blue: a concise review. Am J Hematol. 2007;82(2):134–144.
   PubMed Web of Science ®Google Scholar
• Tejero J, Shiva S, Gladwin MT. Sources of vascular nitric oxide and reactive oxygen species and their regulation. Physiol Rev. 2019;99(1):311–379.
   PubMed Web of Science ®Google Scholar
• Kim-Shapiro DB, Schechter AN, Gladwin MT. Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler Thromb Vasc Biol. 2006;26(4):697–705.
   PubMed Web of Science ®Google Scholar
• Chen K, Piknova B, Pittman RN, et al. Nitric oxide from nitrite reduction by hemoglobin in the plasma and erythrocytes. Nitric Oxide. 2008;18(1):47–60.
   PubMed Web of Science ®Google Scholar
• Jia L, Bonaventura C, Bonaventura J, et al. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature. 1996;380(6571):221–226.
   PubMed Web of Science ®Google Scholar
• Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87(1):315–424.
   PubMed Web of Science ®Google Scholar
• Cortese-Krott MM, Kelm M. Endothelial nitric oxide synthase in red blood cells: key to a new erythrocrine function? Redox Biol. 2014;2:251–258.
   PubMed Web of Science ®Google Scholar
• Radi R. Peroxynitrite, a stealthy biological oxidant. J Biol Chem. 2013;288(37):26464–26472.
   PubMed Web of Science ®Google Scholar
• Fibach E, Rachmilewitz E. The role of oxidative stress in hemolytic anemia. Curr Mol Med. 2008;8(7):609–619.
   PubMed Web of Science ®Google Scholar
• Voskou S, Aslan M, Fanis P, et al. Oxidative stress in β-thalassaemia and sickle cell disease. Redox Biol. 2015;6:226–239.
   PubMed Web of Science ®Google Scholar
• Fujii J, Kurahashi T, Konno T, et al. Oxidative stress as a potential causal factor for autoimmune hemolytic anemia and systemic lupus erythematosus. World J Nephrol. 2015;4(2):213–222.
   PubMedGoogle Scholar
• Ito K, Hirao A, Arai F, et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med. 2006;12(4):446–451.
   PubMed Web of Science ®Google Scholar
• Rhee SG, Woo HA, Kil IS, et al. Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides. J Biol Chem. 2012;287(7):4403–4410.
   PubMed Web of Science ®Google Scholar
• Fujii J, Ito JI, Zhang X, et al. Unveiling the roles of the glutathione redox system in vivo by analyzing genetically modified mice. J Clin Biochem Nutr. 2011;49(2):70–78.
   PubMed Web of Science ®Google Scholar
• McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244(22):6049–6055.
   PubMed Web of Science ®Google Scholar
• Fukai T, Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal. 2011;15(6):1583–1606.
   PubMed Web of Science ®Google Scholar
• Flynn JM, Melov S. SOD2 in mitochondrial dysfunction and neurodegeneration. Free Radic Biol Med. 2013;62:4–12.
   PubMed Web of Science ®Google Scholar
• Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem. 1995;64:97–112.
   PubMed Web of Science ®Google Scholar
• Tainer JA, Getzoff ED, Richardson JS, et al. Structure and mechanism of copper, zinc superoxide dismutase. Nature. 1983;306(5940):284–287.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Shibuya S, Ozawa Y, et al. Superoxide dismutase 1 loss disturbs intracellular redox signaling, resulting in global age-related pathological changes. Biomed Res Int. 2014;2014:140165.
   PubMed Web of Science ®Google Scholar
• Meissner F, Molawi K, Zychlinsky A. Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat Immunol. 2008;9(8):866–872.
   PubMed Web of Science ®Google Scholar
• Lei XG, Zhu JH, McClung JP, et al. Mice deficient in Cu,Zn-superoxide dismutase are resistant to acetaminophen toxicity. Biochem J. 2006;399(3):455–461.
   PubMedGoogle Scholar
• Shirato T, Homma T, Lee J, et al. Oxidative stress caused by a SOD1 deficiency ameliorates thioacetamide-triggered cell death via CYP2E1 inhibition but stimulates liver steatosis. Arch Toxicol. 2017;91(3):1319–1333.
   PubMed Web of Science ®Google Scholar
• Reaume AG, Elliott JL, Hoffman EK, et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet. 1996;13(1):43–47.
   PubMed Web of Science ®Google Scholar
• Ho YS, Gargano M, Cao J, et al. Reduced fertility in female mice lacking copper-zinc superoxide dismutase. J Biol Chem. 1998;273(13):7765–7769.
   PubMed Web of Science ®Google Scholar
• Matzuk MM, Dionne L, Guo Q, et al. Ovarian function in superoxide dismutase 1 and 2 knockout mice. Endocrinology. 1998;139(9):4008–4011.
   PubMed Web of Science ®Google Scholar
• Iuchi Y, Okada F, Onuma K, et al. Elevated oxidative stress in erythrocytes due to a SOD1 deficiency causes anaemia and triggers autoantibody production. Biochem J. 2007;402(2):219–227.
   PubMedGoogle Scholar
• Starzyński RR, Canonne-Hergaux F, Willemetz A, et al. Haemolytic anaemia and alterations in hepatic iron metabolism in aged mice lacking Cu,Zn-superoxide dismutase. Biochem J. 2009;420(3):383–390.
   PubMedGoogle Scholar
• Iuchi Y, Okada F, Takamiya R, et al. Rescue of anaemia and autoimmune responses in SOD1-deficient mice by transgenic expression of human SOD1 in erythrocytes. Biochem J. 2009;422(2):313–320.
   PubMedGoogle Scholar
• Yoshihara D, Fujiwara N, Ookawara T, et al. Protective role of glutathione S-transferase A4 induced in copper/zinc-superoxide dismutase knockout mice. Free Radic Biol Med. 2009;47(5):559–567.
   PubMed Web of Science ®Google Scholar
• Yoshihara D, Fujiwara N, Kato S, et al. Alterations in renal iron metabolism caused by a copper/zinc-superoxide dismutase deficiency. Free Radic Res. 2012;46(6):750–757.
   PubMed Web of Science ®Google Scholar
• Iuchi Y, Kibe N, Tsunoda S, et al. Implication of oxidative stress as a cause of autoimmune hemolytic anemia in NZB mice. Free Radic Biol Med. 2010;48(7):935–944.
   PubMed Web of Science ®Google Scholar
• Guo Z, Higuchi K, Mori M. Spontaneous hypomorphic mutations in antioxidant enzymes of mice. Free Radic Biol Med. 2003;35(12):1645–1652.
   PubMed Web of Science ®Google Scholar
• Konno T, Otsuki N, Kurahashi T, et al. Reactive oxygen species exacerbate autoimmune hemolytic anemia in New Zealand Black mice. Free Radic Biol Med. 2013;65:1378–1384.
   PubMed Web of Science ®Google Scholar
• Otsuki N, Konno T, Kurahashi T, et al. The SOD1 transgene expressed in erythroid cells alleviates fatal phenotype in congenic NZB/NZW-F1 mice. Free Radic Res. 2016;50(7):793–800.
   PubMed Web of Science ®Google Scholar
• Homma T, Takeda Y, Sakahara S, et al. Heterozygous SOD1 deficiency in mice with an NZW background causes male infertility and an aberrant immune phenotype. Free Radic Res. 2019;53(11–12):1060–1072.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Ito F, Yamashita K, et al. Iron and thiol redox signaling in cancer: an exquisite balance to escape ferroptosis. Free Radic Biol Med. 2017;108:610–626.
   PubMed Web of Science ®Google Scholar
• Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med. 2020;152:175–185.
   PubMed Web of Science ®Google Scholar
• Attri S, Sharma N, Jahagirdar S, et al. Erythrocyte metabolism and antioxidant status of patients with Wilson disease with hemolytic anemia. Pediatr Res. 2006;59(4):593–597.
   PubMed Web of Science ®Google Scholar
• Culotta VC, Yang M, O’Halloran TV. Activation of superoxide dismutases: putting the metal to the pedal. Biochim Biophys Acta. 2006;1763(7):747–758.
   PubMed Web of Science ®Google Scholar
• Wong PC, Waggoner D, Subramaniam JR, et al. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc Natl Acad Sci USA. 2000;97(6):2886–2891.
   PubMed Web of Science ®Google Scholar
• Bertinato J, Sherrard L, Plouffe LJ. Decreased erythrocyte CCS content is a biomarker of copper overload in rats. Int J Mol Sci. 2010;11(7):2624–2635.
   PubMed Web of Science ®Google Scholar
• Lassi KC, Prohaska JR. Erythrocyte copper chaperone for superoxide dismutase is increased following marginal copper deficiency in adult and postweanling mice. J Nutr. 2012;142(2):292–297.
   PubMed Web of Science ®Google Scholar
• Seidl R, Cairns N, Lubec G. The brain in Down syndrome. J Neural Transm Suppl. 2001;61:247–261.
   PubMedGoogle Scholar
• Hayashi Y, Homma K, Ichijo H. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS. Adv Biol Regul. 2016;60:95–104.
   PubMedGoogle Scholar
• Li Y, Huang TT, Carlson EJ, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet. 1995;11(4):376–381.
   PubMed Web of Science ®Google Scholar
• Friedman JS, Rebel VI, Derby R, et al. Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant. J Exp Med. 2001;193(8):925–934.
   PubMed Web of Science ®Google Scholar
• Friedman JS, Lopez MF, Fleming MD, et al. SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood. 2004;104(8):2565–2573.
   PubMed Web of Science ®Google Scholar
• Martin FM, Bydlon G, Friedman JS. SOD2-deficiency sideroblastic anemia and red blood cell oxidative stress. Antioxid Redox Signal. 2006;8(7–8):1217–1225.
   PubMed Web of Science ®Google Scholar
• Mohanty JG, Nagababu E, Friedman JS, et al. SOD2 deficiency in hematopoietic cells in mice results in reduced red blood cell deformability and increased heme degradation. Exp Hematol. 2013;41(3):316–321.
   PubMed Web of Science ®Google Scholar
• Martin FM, Xu X, von Löhneysen K, et al. SOD2 deficient erythroid cells up-regulate transferrin receptor and down-regulate mitochondrial biogenesis and metabolism. PLoS One. 2011;6(2):e16894.
   PubMed Web of Science ®Google Scholar
• Fidler TP, Rowley JW, Araujo C, et al. Superoxide dismutase 2 is dispensable for platelet function. Thromb Haemost. 2017;117(10):1859–1867.
   PubMed Web of Science ®Google Scholar
• Mueller S, Riedel HD, Stremmel W. Direct evidence for catalase as the predominant H2O2 -removing enzyme in human erythrocytes. Blood. 1997;90(12):4973–4978.
   PubMed Web of Science ®Google Scholar
• Góth L, Nagy T. Inherited catalase deficiency: is it benign or a factor in various age related disorders? Mutat Res. 2013;753(2):147–154.
   PubMed Web of Science ®Google Scholar
• Nagy T, Paszti E, Kaplar M, et al. Further acatalasemia mutations in human patients from Hungary with diabetes and microcytic anemia. Mutat Res. 2015;772:10–14.
   PubMed Web of Science ®Google Scholar
• Ho YS, Xiong Y, Ma W, et al. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem. 2004;279(31):32804–32812.
   PubMed Web of Science ®Google Scholar
• Johnson RM, Ho YS, Yu DY, et al. The effects of disruption of genes for peroxiredoxin-2, glutathione peroxidase-1, and catalase on erythrocyte oxidative metabolism. Free Radic Biol Med. 2010;48(4):519–525.
   PubMed Web of Science ®Google Scholar
• Benhar M. Roles of mammalian glutathione peroxidase and thioredoxin reductase enzymes in the cellular response to nitrosative stress. Free Radic Biol Med. 2018;127:160–164.
   PubMed Web of Science ®Google Scholar
• Ho YS, Magnenat JL, Bronson RT, et al. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem. 1997;272(26):16644–16651.
   PubMed Web of Science ®Google Scholar
• Johnson RM, Goyette G, Jr, Ravindranath Y, et al. Red cells from glutathione peroxidase-1-deficient mice have nearly normal defenses against exogenous peroxides. Blood. 2000;96(5):1985–1988.
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072.
   PubMed Web of Science ®Google Scholar
• Ingold I, Berndt C, Schmitt S, et al. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell. 2018;172(3):409–422.
   PubMed Web of Science ®Google Scholar
• Rhee SG, Kil IS. Multiple functions and regulation of mammalian peroxiredoxins. Annu Rev Biochem. 2017;86:749–775.
   PubMed Web of Science ®Google Scholar
• Fujii J, Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep. 2002;7(3):123–130.
   PubMed Web of Science ®Google Scholar
• Low FM, Hampton MB, Winterbourn CC. Peroxiredoxin 2 and peroxide metabolism in the erythrocyte. Antioxid Redox Signal. 2008;10(9):1621–1630.
   PubMed Web of Science ®Google Scholar
• Taketani S, Adachi Y, Kohno H, et al. Molecular characterization of a newly identified heme-binding protein induced during differentiation of urine erythroleukemia cells. J Biol Chem. 1998;273(47):31388–31394.
   PubMed Web of Science ®Google Scholar
• Schröder E, Littlechild JA, Lebedev AA, et al. Crystal structure of decameric 2-Cys peroxiredoxin from human erythrocytes at 1.7 Å resolution. Structure. 2000;8(6):605–615.
   PubMed Web of Science ®Google Scholar
• Rhee SG, Woo HA. Multiple functions of peroxiredoxins: peroxidases, sensors and regulators of the intracellular messenger H2O2, and protein chaperones. Antioxid Redox Signal. 2011;15(3):781–794.
   PubMed Web of Science ®Google Scholar
• Yang KS, Kang SW, Woo HA, et al. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J Biol Chem. 2002;277(41):38029–38036.
   PubMed Web of Science ®Google Scholar
• Moon JC, Hah YS, Kim WY, et al. Oxidative stress-dependent structural and functional switching of a human 2-Cys peroxiredoxin isotype II that enhances HeLa cell resistance to H2O2-induced cell death. J Biol Chem. 2005;280(31):28775–28784.
   PubMed Web of Science ®Google Scholar
• Lee CK, Kim HJ, Lee YR, et al. Analysis of peroxiredoxin decreasing oxidative stress in hypertensive aortic smooth muscle. Biochim Biophys Acta. 2007;1774(7):848–855.
   PubMed Web of Science ®Google Scholar
• Lim JC, Choi HI, Park YS, et al. Irreversible oxidation of the active-site cysteine of peroxiredoxin to cysteine sulfonic acid for enhanced molecular chaperone activity. J Biol Chem. 2008;283(43):28873–28880.
   PubMed Web of Science ®Google Scholar
• Biteau B, Labarre J, Toledano MB. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature. 2003;425(6961):980–984.
   PubMed Web of Science ®Google Scholar
• Woo HA, Jeong W, Chang TS, et al. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J Biol Chem. 2005;280(5):3125–3128.
   PubMed Web of Science ®Google Scholar
• Cho CS, Lee S, Lee GT, et al. Irreversible inactivation of glutathione peroxidase 1 and reversible inactivation of peroxiredoxin II by H2O2 in red blood cells. Antioxid Redox Signal. 2010;12(11):1235–1246.
   PubMed Web of Science ®Google Scholar
• O’Neill JS, Reddy AB. Circadian clocks in human red blood cells. Nature. 2011;469(7331):498–503.
   PubMed Web of Science ®Google Scholar
• Cho CS, Yoon HJ, Kim JY, et al. Circadian rhythm of hyperoxidized peroxiredoxin II is determined by hemoglobin autoxidation and the 20S proteasome in red blood cells. Proc Natl Acad Sci USA. 2014;111:1–6.
   Web of Science ®Google Scholar
• Low FM, Hampton MB, Peskin AV, et al. Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood. 2007;109(6):2611–2617.
   PubMed Web of Science ®Google Scholar
• Homma T, Okano S, Lee J, et al. SOD1 deficiency induces the systemic hyperoxidation of peroxiredoxin in the mouse. Biochem Biophys Res Commun. 2015;463(4):1040–1046.
   PubMed Web of Science ®Google Scholar
• Homma T, Kurahashi T, Lee J, et al. SOD1 deficiency decreases proteasomal function, leading to the accumulation of ubiquitinated proteins in erythrocytes. Arch Biochem Biophys. 2015;583:65–72.
   PubMed Web of Science ®Google Scholar
• Lee TH, Kim SU, Yu SL, et al. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood. 2003;101(12):5033–5038.
   PubMed Web of Science ®Google Scholar
• Han YH, Kwon T, Kim SU, et al. Peroxiredoxin I deficiency attenuates phagocytic capacity of macrophage in clearance of the red blood cells damaged by oxidative stress. BMB Rep. 2012;45(10):560–564.
   PubMed Web of Science ®Google Scholar
• Bayer SB, Low FM, Hampton MB, et al. Interactions between peroxiredoxin 2, hemichrome and the erythrocyte membrane. Free Radic Res. 2016;50(12):1329–1339.
   PubMed Web of Science ®Google Scholar
• Rocha S, Vitorino RM, Lemos-Amado FM, et al. Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis. Blood Cells Mol Dis. 2008;41(1):5–9.
   PubMed Web of Science ®Google Scholar
• Rocha S, Costa E, Rocha-Pereira P, et al. Erythrocyte membrane protein destabilization versus clinical outcome in 160 Portuguese hereditary spherocytosis patients. Br J Haematol. 2010;149(5):785–794.
   PubMed Web of Science ®Google Scholar
• Rocha S, Rocha-Pereira P, Cleto E, et al. Linkage of typically cytosolic peroxidases to erythrocyte membrane - a possible mechanism of protection in hereditary spherocytosis. Biochim Biophys Acta Biomembr. 2020;1862(3):183172.
   PubMed Web of Science ®Google Scholar
• Neumann CA, Krause DS, Carman CV, et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature. 2003;424(6948):561–565.
   PubMed Web of Science ®Google Scholar
• Uwayama J, Hirayama A, Yanagawa T, et al. Tissue Prx I in the protection against Fe-NTA and the reduction of nitroxyl radicals. Biochem Biophys Res Commun. 2006;339(1):226–231.
   PubMed Web of Science ®Google Scholar
• Han YH, Kim SU, Kwon TH, et al. Peroxiredoxin II is essential for preventing hemolytic anemia from oxidative stress through maintaining hemoglobin stability. Biochem Biophys Res Commun. 2012;426(3):427–432.
   PubMed Web of Science ®Google Scholar
• Shang F, Taylor A. Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radic Biol Med. 2011;51(1):5–16.
   PubMed Web of Science ®Google Scholar
• Davies KJ. Degradation of oxidized proteins by the 20S proteasome. Biochimie. 2001;83(3–4):301–310.
   PubMed Web of Science ®Google Scholar
• Orlowski M, Wilk S. Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex. Arch Biochem Biophys. 2000;383(1):1–16.
   PubMed Web of Science ®Google Scholar
• Pacifici RE, Salo DC, Davies KJ. Macroxyproteinase (M.O.P.): a 670 kDa proteinase complex that degrades oxidatively denatured proteins in red blood cells. Free Radic Biol Med. 1989;7(5):521–536.
   PubMed Web of Science ®Google Scholar
• Pacifici RE, Kono Y, Davies KJ. Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome. J Biol Chem. 1993;268(21):15405–15411.
   PubMed Web of Science ®Google Scholar
• Khandros E, Weiss MJ. Protein quality control during erythropoiesis and hemoglobin synthesis. Hematol Oncol Clin North Am. 2010;24(6):1071–1088.
   PubMed Web of Science ®Google Scholar
• Khandros E, Thom CS, D’Souza J, et al. Integrated protein quality-control pathways regulate free α-globin in murine β-thalassemia. Blood. 2012;119(22):5265–5275.
   PubMed Web of Science ®Google Scholar
• Basu A, Saha S, Karmakar S, et al. 2D DIGE based proteomics study of erythrocyte cytosol in sickle cell disease: altered proteostasis and oxidative stress. Proteomics. 2013;13(21):3233–3242.
   PubMed Web of Science ®Google Scholar
• Cho CS, Kato GJ, Yang SH, et al. Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia. Antioxid Redox Signal. 2010;13(1):1–11.
   PubMed Web of Science ®Google Scholar
• Biondani A, Turrini F, Carta F, et al. Heat-shock protein-27, -70 and peroxiredoxin-II show molecular chaperone function in sickle red cells: evidence from transgenic sickle cell mouse model. Proteomics Clin Appl. 2008;2(5):706–719.
   PubMed Web of Science ®Google Scholar
• Majetschak M, Sorell LT. Immunological methods to quantify and characterize proteasome complexes: development and application. J Immunol Methods. 2008;334(1–2):91–103.
   PubMed Web of Science ®Google Scholar
• Reinhecke T, Sitte N, Ullrich O, et al. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J. 1998;335(3):637–642.
   PubMedGoogle Scholar
• Homma T, Fujii J. Emerging connections between oxidative stress, defective proteolysis, and metabolic diseases. Free Radic Res. 2020; Apr 20:1–16.
   Google Scholar
• Waite KA, De-La Mota-Peynado A, Vontz G, et al. Starvation induces proteasome autophagy with different pathways for core and regulatory particles. J Biol Chem. 2016;291(7):3239–3253.
   PubMed Web of Science ®Google Scholar
• Chirico EN, Pialoux V. Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMB Life. 2012;64(1):72–80.
   PubMed Web of Science ®Google Scholar
• Warang P, Homma T, Pandya R, et al. Potential involvement of ubiquitin-proteasome system dysfunction associated with oxidative stress in the pathogenesis of sickle cell disease. Br J Haematol. 2018;182(4):559–566.
   PubMed Web of Science ®Google Scholar
• Pullarkat V, Meng Z, Tahara SM, et al. Proteasome inhibition induces both antioxidant and hb f responses in sickle cell disease via the nrf2 pathway. Hemoglobin. 2014;38(3):188–195.
   PubMed Web of Science ®Google Scholar
• Telen MJ. Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease. Blood. 2016;127(7):810–819.
   PubMed Web of Science ®Google Scholar
• Costa FC, da Cunha AF, Fattori A, et al. Gene expression profiles of erythroid precursors characterise several mechanisms of the action of hydroxycarbamide in sickle cell anaemia. Br J Haematol. 2007;136(2):333–342.
   PubMed Web of Science ®Google Scholar
• Cokic VP, Smith RD, Beleslin-Cokic BB, et al. Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. J Clin Invest. 2003;111(2):231–239.
   PubMed Web of Science ®Google Scholar
• Cokic VP, Beleslin-Cokic BB, Noguchi CT, et al. Hydroxyurea increases eNOS Protein levels through inhibition of proteasome activity. Nitric Oxide. 2007;16(3):371–379.
   PubMed Web of Science ®Google Scholar
• Huang J, Sommers EM, Kim-Shapiro DB, et al. Horseradish peroxidase catalyzed nitric oxide formation from hydroxyurea. J Am Chem Soc. 2002;124(13):3473–3480.
   PubMed Web of Science ®Google Scholar
• Huang J, Kim-Shapiro DB, King SB. Catalase-mediated nitric oxide formation from hydroxyurea. J Med Chem. 2004;47(14):3495–3501.
   PubMed Web of Science ®Google Scholar
• Italia K, Chandrakala S, Ghosh K, et al. Can hydroxyurea serve as a free radical scavenger and reduce iron overload in β-thalassemia patients? Free Radic Res. 2016;50(9):959–965.
   PubMed Web of Science ®Google Scholar